Evidence map›Paper›PMID 22836235›Full record

ArticleCell stress & chaperones2013

Dynamics of endogenous Hsp70 synthesis in the brain of olfactory bulbectomized mice.

Natalia Bobkova, Irina Guzhova, Boris Margulis, Inna Nesterova, Natalia Medvinskaya, Natalia Medvedinskaya, Alexander Samokhin, Irina Alexandrova, David Garbuz, Evgeny Nudler and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell stress & chaperones, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

  • Erratum issued
    Medvedinskaya, Natalia [corrected to Medvinskaya, Natalia]
5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Natalia BobkovaInstitute of Cell Biophysics, RAS, Pushchino, Moscow Region, 142290, Russia.
Irina Guzhova
Boris Margulis
Inna Nesterova
Natalia Medvinskaya
Natalia Medvedinskaya
Alexander Samokhin
Irina Alexandrova
David Garbuz
Evgeny Nudler
Michael Evgen'ev
Institute of Cell Biophysics · RUEngelhardt Institute of Molecular Biology · RUInstitute of Cytology · RUNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous epidemiological studies have established acute brain injury as one of the major risk factors for the Alzheimer's disease (AD). However, the lack of animal models of AD-like degeneration triggered by a defined injury hampered the development of adequate therapies. Here we report that the surgical damage of the olfactory bulbs triggers the development of several pathologies, including amyloid-β accumulation and strong decrease of neuron density in the cortex and hippocampus as well as significant disturbance of spatial memory. Characteristically, these harmful consequences of the olfactory bulbectomy (OBX) have a peculiar dynamics in time with maximal manifestation in periods of 1-1.5 months and 8 months after the surgery and, hence, exhibit biphasic pattern with almost complete recovery period taking place at 5-6 months after the operation. The quantitative determination of endogenous inducible form of Hsp70 in different brain areas of OBX mice demonstrated characteristic fluctuations of Hsp70 levels depending on the time after the operation and age of mice. Interestingly, maximal induction of Hsp70 synthesis in the hippocampus exhibits clear-cut coincidence with the recovery period in OBX animals. The observed correlation enables to suggest curing effect of Hsp70 synthesis at an earlier period of pathology development and establishes it as a possible therapeutic agent for secondary grave consequences of brain injury, such as AD-like degeneration, for which neuroprotective therapy is urgently needed.

Indexed as

Amyloid beta-PeptidesAnimalsBehavior, AnimalBrainHippocampusHSP70 Heat-Shock ProteinsMaleMiceOlfactory BulbTime FactorsAmyloid beta-PeptidesHSP70 Heat-Shock Proteins

Identifiers

PMID22836235
PMCPMC3508132
OpenAlexW1967504616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.